Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Oxiconazole nitrate cream is effective and safe for treating various fungal skin infections.

Clofazimine effectively treated ashy dermatosis in a patient.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

A woman with Fox-Fordyce disease had symptom relief using tretinoin cream.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.